A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
University of Nebraska
University of Nebraska
National Cancer Institute (NCI)
Novartis
M.D. Anderson Cancer Center
Mayo Clinic
Children's Oncology Group
Novartis
Wake Forest University Health Sciences
Melbourne Health
Washington University School of Medicine
Servier
Washington University School of Medicine
University of Florida
Nuvation Bio Inc.
Dana-Farber Cancer Institute
Universität Münster
The Cooper Health System
Abramson Cancer Center at Penn Medicine
St. Jude Children's Research Hospital
University Hospital Heidelberg
Hospices Civils de Lyon
Alliance for Clinical Trials in Oncology